loader image
Saturday, December 20, 2025
89 F
McAllen
- Advertisement -

Clot-Busting Drug May Be Safe for People with Stroke and Unruptured Aneurysms

Translate to Spanish or other 102 languages!

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. Image for illustration purposes.

Mega Doctor News

- Advertisement -

By American Academy of Neurology (AAN)

Newswise — MINNEAPOLIS – Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain. A new study finds that these aneurysms rarely burst after treatment with clot-busting drugs, so the drugs may be safe for use. The study is published in the October 6, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.

“These results are exciting because they may expand the population who can receive these thrombolytic therapies that can prevent death and disability for people with strokes,” said study author Jyri Juhani Virta, MD, PhD, of the University of Helsinki in Finland.

- Advertisement -

For the study, researchers looked at the records for all people with a stroke who were treated with clot-busting drugs at a stroke center in Finland over 15 years. After determining how many had unruptured aneurysms, they then looked to see how many people had a hemorrhagic stroke, or an intracranial hemorrhage, caused by the rupture of the aneurysm while they were in the hospital after the treatment.

Of the 3,953 people in the study, 132 people had one or more unruptured aneurysms. Of the 155 unruptured aneurysms, 141 were the type called saccular aneurysms and 14 were fusiform aneurysms.

The aneurysms ruptured after treatment causing a hemorrhagic stroke in only three people, or 2.3%. All three had large aneurysms called fusiform basilar artery aneurysms. All three were treated with blood thinners after their treatment. None of the saccular type of aneurysms ruptured.

“Fortunately, today blood thinners are not commonly used early after ischemic stroke, so that may help to reduce this risk even further,” Virta said. “Our results suggest that thrombolytic therapy may be relatively safe for people with ischemic stroke even if they have larger saccular aneurysms that have not ruptured. For people with large fusiform aneurysms, additional consideration should be taken regarding treatment as blood thinners may increase the risk of aneurysm rupture.”

- Advertisement -

 A limitation of the study was that only a small number of people had large aneurysms.

Learn more about stroke at BrainandLife.org, home of the American Academy of Neurology’s free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram. #Neurology and #AANscience.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 

DHR Health Awarded Large Employer of the Year by Texas Workforce Commission

Workforce Solutions Lower Rio Grande Valley (WFS) proudly announced that its nominee, DHR Health, has been awarded the Large Employer of the Year Award at the 28th Annual Texas Workforce Commission (TWC) Conference.

3D-Printed Models Improve Precision in Cancer Surgery

Using custom 3D-printed models to plan head and neck cancer surgeries increased precision, achieving complete tumor removal in 92% of cases with bone invasion in a recent study published by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
- Advertisement -
×